Neurones S.A. (EPA:NRO)
France flag France · Delayed Price · Currency is EUR
38.15
-0.30 (-0.78%)
Jul 31, 2026, 5:35 PM CET

Neurones Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
61.8663.2358.5851.7742.94
Depreciation & Amortization
19.5517.6616.7616.5714.68
Stock-Based Compensation
4.215.114.393.361.99
Other Adjustments
14.1414.7416.320.5919
Changes in Income Taxes Payable
-27.84-24.81-25.35-24.13-16.16
Changes in Other Operating Activities
8.8518.656.3-13.222.23
Operating Cash Flow
71.2884.3872.0854.9764.5
Operating Cash Flow Growth
-15.53%17.08%31.12%-14.77%-4.15%
Sale of Property, Plant & Equipment
0.090.260.080.060.16
Purchases of Intangible Assets
-10.44-12.04-17.98-10.61-6.58
Purchases of Investments
-1.44-1.79-2.07-1.71-1.1
Proceeds from Sale of Investments
0.710.320.850.310.5
Cash Acquisitions
-4.84-2.16-3.18-0.31-2.62
Proceeds from Business Divestments
0.150.141.090.50.07
Investing Cash Flow
-21.16-19.69-21.57-12.26-10.62
Long-Term Debt Issued
2.495.116.390.070.02
Long-Term Debt Repaid
-13.73-12.44-9.98-7.14-6.62
Net Long-Term Debt Issued (Repaid)
-11.23-7.33-3.59-7.07-6.61
Repurchase of Common Stock
-0.32-0.030.06-0.110.09
Net Common Stock Issued (Repurchased)
-0.32-0.030.06-0.110.09
Common Dividends Paid
-31.62-29.13-26.65-24.22-48.42
Other Financing Activities
-7.33-12.61-2.14-5.14-1.72
Financing Cash Flow
-35.62-34.48-27.06-36.08-55.43
Foreign Exchange Rate Adjustments
-0.280.360.030.250.13
Net Cash Flow
14.5130.2123.456.64-1.55
Free Cash Flow
71.2884.3872.0854.9764.5
Free Cash Flow Growth
-15.53%17.08%31.12%-14.77%-4.15%
FCF Margin
8.32%10.41%9.72%8.26%11.12%
Free Cash Flow Per Share
2.923.472.962.262.66
Levered Free Cash Flow
41.456.7243.5316.3931.86
Unlevered Free Cash Flow
55.5267.4152.7331.0143.57